Today: 21 May 2026
Nebius (NBIS) stock rises after Tavily acquisition, with February 12 earnings next
10 February 2026
2 mins read

Nebius (NBIS) stock rises after Tavily acquisition, with February 12 earnings next

NEW YORK, February 10, 2026, 14:49 EST — Regular session

  • Shares of NBIS climbed roughly 1% following Nebius’ deal to acquire AI agent search provider Tavily.
  • The filing indicates a cash component paid upfront, along with a performance-based earn-out. No price was revealed.
  • Investors now turn to the February 12 results, looking for clues on both demand and spending.

Nebius Group N.V. edged up nearly 1% Tuesday, following news that the Nasdaq-listed AI cloud player will buy Tavily, a firm specializing in real-time search tools for AI agents. NBIS last traded at $93.80, up 0.99% in the afternoon.

Nebius put out the announcement just 48 hours ahead of its fourth-quarter and full-year earnings, throwing another piece of the puzzle to traders watching its efforts to expand the software stack. Results hit before the U.S. market bell on Thursday.

Tavily pitches its “agentic search” software as a way for automated AI agents to grab fresh data from the web as they work, sidestepping reliance on stale training sets. The distinction is getting more important, especially with companies pushing to make AI agents part of everyday operations, not just flashy demos.

Tavily’s search layer is set to connect directly with Nebius’s Token Factory, the company said, aiming to streamline how clients deploy AI models and cut down reliance on outside vendors. “This acquisition brings the search layer directly into our stack,” said Roman Chernin, co-founder and Chief Business Officer. Nebius

Rotem Weiss, founder and CEO of Tavily, described the company as being “on a mission to onboard the next billion AI agents to the web.” According to Nebius, Tavily’s software-development-kit has topped 3 million downloads each month, with IBM, Cohere, and Groq listed as clients. Business Wire

Nebius disclosed in a U.S. securities filing that the upfront payment comes in cash, while extra payouts depend on hitting certain performance goals over a set timeframe. Those earn-out payments could be made in cash, Class A shares, or a mix of both, according to the company. No shareholder vote is needed for the deal.

Nebius kept the purchase price under wraps. Bloomberg, referencing a source with knowledge of the deal, put Tavily’s potential valuation near $275 million.

After a 7.9% surge on Monday, the stock swung between $91.68 and $95.50 in this session—highlighting a choppy stretch as earnings approach.

Nebius offers computing power based on GPUs—hardware central to building and deploying AI models—and has been pushing to boost sales of the software running on that backbone. Back in December, Chernin told Reuters that major deals with Microsoft and Meta were aimed at expanding Nebius’s customer reach. “We should be ready (for when) the winter will come,” he said then. Reuters

Still, the financial details around the Tavily acquisition aren’t clear. The buyout comes while investors are already questioning AI infrastructure firms about their cash burn and capex. If Thursday brings any hint that spending is outpacing demand, the stock could face renewed pressure.

Nebius is set to report earnings and hold its conference call on February 12. Investors are watching for signals on capacity expansion, insight into customer demand, and any early signs of Tavily integration making an impact on product uptake.

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Eli Lilly stock price dips as $2.4 billion Orna deal and China pact grab attention
Previous Story

Eli Lilly stock price dips as $2.4 billion Orna deal and China pact grab attention

Abpro Holdings stock slides in premarket after Goldman stake filing sparks wild ABP swings
Next Story

Abpro Holdings stock slides in premarket after Goldman stake filing sparks wild ABP swings

Go toTop